A nationwide survey of radiation oncologists' management practices of radiation-induced skin reaction (RISK)

Journal of Radiotherapy in Practice

Volumn 8, Issue 4, 2009, Pages 195-205

  Swamy, Uma ^a   Ashamalla, Hani ^a   Guirguis, Adel ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Breast cancer; Radiation reaction; Skin reaction; Survey

Indexed keywords

ALOE VERA EXTRACT; ALPHA TOCOPHEROL; AVEENO; BETAMETHASONE; BIAFINE; CARRASYN; CETAPHIL; CORTISONE; ELTA LITE; HYDROCORTISONE ACETATE; JOHNSON BABY POWDER; LANOLIN ALCOHOL; LUBRIDERM; MIADERM; MOMETASONE FUROATE; NATURAL CARE GEL; NEUROSKIN; PETROLATUM; RAD X; RADIACARE; RADIOCREAM; RADIOPLEX; RECOVERY CREAM; STARCH; SWEEN CREAM; TALC; TOPICAL AGENT; TRIAMCINOLONE; UNCLASSIFIED DRUG; VANICREAM; XCLAIR; XIPAMIDE;

ARTICLE; BREAST; BREAST CANCER; BREAST SIZE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CREAM; ETHNICITY; HEALING; HORMONAL THERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; MEDICAL SPECIALIST; ONCOLOGIST; PROPHYLAXIS; QUESTIONNAIRE; RADIATION DOSE; RADIATION INDUCED SKIN REACTION; RISK FACTOR; SKIN MANIFESTATION; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY;

EID: 74549188365     PISSN: 14603969     EISSN: 14671131     Source Type: Journal    
DOI: 10.1017/S1460396909990227     Document Type: Article

References (59)

1. Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur J Cancer Care 1999; 8:143-153.
2. Freedman GM, Anderson PR, Goldstein LJ, et al. Fourweek course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys. 2007; 68:347-353.
3. White J, Joiner M. Toxicity from radiation in breast cancer. In: Small W, Woloschak GE, (ed). Radiation Toxicity: A Practical Guide. 1st edition. Chicago: Springer, 2006, pp. 65-81.
4. The Research Profession Tracking Study. Published by CMOR, A division of the Marketing Research Association (MRA).
5. Ballou J, Roff B, Milliner-Waddell J, Potter F. Developing a Prescription for Physician Surveys. Paper presented at American Association For Public Opinion Association, Miami Beach, FL 2008-2010-10 http://www.allacademic. com/meta/p17148-index.html.
6. National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, 1-3 November 2000. J Natl Cancer Inst Monogr 2001:5-15.
7. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, Salvadori B, Zucali R. Radiotherapy after breast conserving surgery in small breast carcinoma: long term results of a randomized trial. Ann Oncol 2001; 12:997-1003.
8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233-1241.
9. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty year follow up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N. Engl J Med 2002; 347:1227-1232.
10. Van Dongen JA, Voogd AC, Fentiman IS et al. Long term results of a randomized trial comparing breast conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 2000; 92:1143-1150.
11. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, Salvadori B, Zucali R. Radiotherapy after breast-conserving surgery in small breast carcinoma: long term results of a randomized trial. Ann Oncol 2001; 12:997-1003.
12. Fisher B, Bryant J, Dignam JJ et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20:4141-4149.
13. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish Trial. Lancet 1996; 348:708-713.
14. START Trialists' Group, Bentzen SM, Agarwal RK et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371:1098-1107.
15. START Trialists' Group, Bentzen SM, Agrawal RK et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008; 9:331-341.
16. Owen J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, Haviland J, Bentzen S, Yarnold J. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006; 7:467-471.
17. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, Haviland J, Bentzen S, Owen R. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: longterm results of a randomised trial. Radiother Oncol 2005; 75:9-17.
18. Whelan TJ, et al. Long term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node negative breast cancer. 2008 American Society for Therapeutic Radiology and Oncology (ASTRO) Plenary Session.
19. Pierce LJ, Moughan J, White J, Winchester DP, Owen J, Wilson JF. 1998-1999 Patterns of care process survey of national breast cancer. Int J Radiat Oncol Biol Phys 2005; 62:183-192.
20. Taylor M, Perez C, Halverson K. et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995; 31:753-764
21. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ, Robert NJ. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1992; 10:356-363.
22. Donovan E, Bleakley N, Denholm E et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007; 82:254-264.
23. Pignol JP, Olivotto I, Rakovitch E et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26:2085-2092.
24. Harsolia A, Kestin L, Grills I et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68:1375-1380.
25. Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, Nicolaou N. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 2006; 29:66-70.
26. Yerushalmi R. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Neoplasma 2006; 53:507-510.
27. Omlin A, Amichetti M, Azria D et al. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006; 7:652-666.
28. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378-1387.
29. Bartelink H, Horiot JC, Poortmans P et al. Impact of higher radiation dose on local control and survival in breast conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-110882 trial. J Clin Oncol 2007; 25:3259-3265.
30. Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, Mamelle N, Gérard JP. Role of a 10 Gy boost in the conservative treatment of early breast cancer: results of a randomized trial. J Clin Oncol 1997; 15:963-968.
31. Julian TB, Land SR, Wang Y, et al. Is boost therapy necessary in the treatment of DCIS? J Clin Oncol 26: 2008 (May 20 suppl; abstr 537)
32. Vreling C, Collette L, Fourquet A et al. The influence of the boost in breast conserving therapy on cosmetic outcome in the EORTC boost versus no boost trial. Int J Radiat Oncol Biol Phys 1999; 45:677-685. (Pubitemid 29462649)
33. Oh KS, Kong F-M, Griffith KA, Yanke B, Pierce LJ. Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole breast irradiation. Int J Radiat Oncol Biol Phys 2006; 66:680-686.
34. Benda RK, Yasuda G, Sethi A, Gabram SG, Hinerman RW, Mendenhall NP. Breast boost: are we missing the target? Cancer 2003; 97:905-909.
35. Jacobson G, Betts V, Smith B. Change in volume of lumpectomy cavity during external beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys 2006; 65:1161-1164.
36. Bates AT, Swift CL, Kwa W, Moravan V, Aquino- Parsons C. A computed tomography-based protocol vs conventional clinical mark-up for breast electron boost. Clin Oncol (R Coll Radiol) 2007; 19:349-355.
37. Smitt MC, Birdwell RL, Goffinet DR. Breast electron boost planning: comparison of CT and US. Radiology 2001; 219:203-206.
38. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation induced skin toxicity for women undergoing breast radiation: RTOG 97-13. Int J Radiat Oncol Biol Phys 2000; 48:1307-1310.
39. Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol 2001; 58:333-339.
40. Løkkevik E, Skovlund E, Reitan JB, Hannisdal E, Tanum G. Skin treatment with bepanthen cream versus no cream during radiotherapy. Acta Oncol 1996; 35:1021-1026.
41. Maiche A, Isokangas O, Grohn P. Skin protection by sucralfate cream during electron beam therapy. Acta Oncol 1994; 33:201-203.
42. Maiche AG, Grohn P, Maki-Hokkonen H. Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 1991; 30:395-396.
43. Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J. Double blind randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997; 42:155-161.
44. Williams M, Burk M, Loprinzi C et al. Phase III double blind evaluation of an aloe vera gel as a prophylactic agent for radiation induced skin toxicity. Int J Radiat Oncol Biol Phys 1996; 36:345-349.
45. Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J. A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 2002; 25:442-451.
46. Olsen DL, Raub W Jr, Bradley C, Johnson M, Macias JL, Love V, Markoe A. The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum 2001; 28:543-547.
47. Bostrom A, Lindman H, Swartling C, et al.Potent corticosteroid therapy (mometasone furoate) significantly reduced acute radiation dermatitis: results from a doubleblind, randomized study. Radiother Oncol 2001; 59:257-265.
48. Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, Elias PM, Fritsch PO, Fritsch E. Topical corticosteroid therapy for acute radiation dermatitis: a prospective randomized double blind study. Br J Dermatol 2002; 146:983-991.
49. Potera M, Lookingbill D, Stryker J. Prophylaxis of radiation dermatitis with topical cortisone cream. Radiology 1982; 143:775-777.
50. Szumacher E, Wighton A, Franssen E et al. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 2001; 51:81-86.
51. Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M, Schachter J, Malik H, Sulkes A, Gutman H. Topical Biafine and Lipiderm for the prevention of radiation dermatitis: A randomized prospective trial. Once Rep 2001; 8:305-309.
52. Pommier P, Gomez F, Sunyach MP, D'Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with Trolamine for the prevention of acute dermatitis during irradiation of breast cancer. J Clin Oncol 2004; 22:1447-1453.
53. www.drugstore.com. Accessed 18 May 2009.
54. Pezner RD, Patterson MP, Lipsett JA, Odom-Maryon T, Vora NL, Wong JY, Luk KH. Factors affecting cosmetic outcome in breast-conserving cancer treatment-objective quantitative assessment. Breast Cancer Rest Treat 1991; 20:85-92.
55. Ryoo M, Kagan AR, Wollin M et al. Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma? Radiology 1989; 172:555-559.
56. De La Rochefordière A, Abner AL, Silver B, Vicini F, Recht A, Harris JR. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys 1992; 23:925-931.
57. Taylor M, Perez C, Halverson K et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995; 31:753-764.
58. Grann A, McCormick B, Chabner ES, Gollamudi SV, Schupak KD, Mychalczak BR, Heerdt AS, Merchant TE, Hunt MA. Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 2000; 47:319-325.
59. Mahe MA, Classe JM, Dravet F, Cussac A, Cuilliere JC. Preliminary results for prone-position breast irradiation. Int J Radiat Oncol Biol Phys 2002; 52:156-160.